drugset / Trial / NCT00941304

Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain

NCT00941304

Phase 2 Completed 153 enrolled BioDelivery Sciences International
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the activity of buprenorphine hydrochloride (HCl) buccal film in the treatment of dental pain.

Timeline

Start
2009-08
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 0.25 mg Other
Subject Buprenorphine Other / unclassified 0.5 mg Other
Comparator Oxycodone Other / unclassified 5 mg Oral

Indications